Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wiseman

Showing results (111-120 of 191) with videos related to

Pageof 20
Sort By:
Journal of the American Academy of Dermatology|July 16, 2005
Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian populationAlain A Demers, Zoann Nugent, Catalin Mihalcioiu, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|May 14, 2009
Use of oral miltefosine for cutaneous leishmaniasis in Canadian soldiers returning from AfghanistanYoav Keynan, Oscar E Larios, Marni C Wiseman, et al.
Clinical Transplants|August 19, 2015
High-Dose Intravenous Immunoglobulin Therapy for Donor Specific Antibodies in Kidney Transplant Recipients with Acute and Chronic Graft Dysfunction: Updates on Previously Reported CohortsJavier Alfonso, Jane Gralla, Patrick Klem, et al.
Human Genetics|December 15, 1976
Cytogenetic survey of a hospital for the mentally retardedG R Sutherland, A R Murch, A J Gardiner, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|March 24, 2017
De Novo Donor-Specific Antibody Formation in Tacrolimus-Based, Mycophenolate Versus Mammalian Target of Rapamycin Immunosuppressive RegimensZain Mithani, Jane Gralla, Oluwafisayo Adebiyi, et al.
Cancer|March 15, 1982
Inflammatory breast cancer treated with surgery, chemotherapy and allogeneic tumor cell/BCG immunotherapyC Wiseman, J M Jessup, T L Smith, et al.
Transplantation|March 16, 2011
Inferior kidney allograft outcomes in patients with de novo donor-specific antibodies are due to acute rejection episodesJames E Cooper, Jane Gralla, Linda Cagle, et al.
Journal of Renal Care|October 3, 2018
Academic achievement and employment in young adults with end-stage kidney diseasePeter D Murray, Maximillian H Brodermann, Jane Gralla, et al.
Transplantation Proceedings|May 14, 2003
Fixed-dose sirolimus with reduced dose calcineurin inhibitor: the University of Colorado experienceA C Wiseman, I Kam, U Christians, et al.
Clinical Transplantation|September 17, 2013
Wound events in kidney transplant patients receiving de novo everolimus: a pooled analysis of three randomized controlled trialsM Cooper, A C Wiseman, G Zibari, et al.
Pageof 20

Showing results (111-120 of 191) with videos related to

Sort By:
Pageof 20
Journal of the American Academy of Dermatology|July 16, 2005
Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian populationAlain A Demers, Zoann Nugent, Catalin Mihalcioiu, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|May 14, 2009
Use of oral miltefosine for cutaneous leishmaniasis in Canadian soldiers returning from AfghanistanYoav Keynan, Oscar E Larios, Marni C Wiseman, et al.
Clinical Transplants|August 19, 2015
High-Dose Intravenous Immunoglobulin Therapy for Donor Specific Antibodies in Kidney Transplant Recipients with Acute and Chronic Graft Dysfunction: Updates on Previously Reported CohortsJavier Alfonso, Jane Gralla, Patrick Klem, et al.
Human Genetics|December 15, 1976
Cytogenetic survey of a hospital for the mentally retardedG R Sutherland, A R Murch, A J Gardiner, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|March 24, 2017
De Novo Donor-Specific Antibody Formation in Tacrolimus-Based, Mycophenolate Versus Mammalian Target of Rapamycin Immunosuppressive RegimensZain Mithani, Jane Gralla, Oluwafisayo Adebiyi, et al.
Cancer|March 15, 1982
Inflammatory breast cancer treated with surgery, chemotherapy and allogeneic tumor cell/BCG immunotherapyC Wiseman, J M Jessup, T L Smith, et al.
Transplantation|March 16, 2011
Inferior kidney allograft outcomes in patients with de novo donor-specific antibodies are due to acute rejection episodesJames E Cooper, Jane Gralla, Linda Cagle, et al.
Journal of Renal Care|October 3, 2018
Academic achievement and employment in young adults with end-stage kidney diseasePeter D Murray, Maximillian H Brodermann, Jane Gralla, et al.
Transplantation Proceedings|May 14, 2003
Fixed-dose sirolimus with reduced dose calcineurin inhibitor: the University of Colorado experienceA C Wiseman, I Kam, U Christians, et al.
Clinical Transplantation|September 17, 2013
Wound events in kidney transplant patients receiving de novo everolimus: a pooled analysis of three randomized controlled trialsM Cooper, A C Wiseman, G Zibari, et al.
Pageof 20